EUCTR2016-001398-34-CZ
Active, not recruiting
Phase 1
A prospective, randomized study to assess the effect of autologous bone marrow-derived mononuclear cell therapy and its combination with percutaneous transluminal angioplasty (PTA) in comparison with repeated PTA in diabetic patients with peripheral arterial disease
ConditionsIn our study, the effect of autologous cell therapy (ACT) will be compared with repeated percutaneous transluminal angioplasty (re-PTA) in patients with diabetic foot and then will be compared the effect of combination treatment of ACT and re-PTA against re-PTA itself. We suppose an enhanced effect of this combination on on macro- and microcirculation. Expected results of the project include improved tissue oxygenation, enhanced DF healing and a reduced risk of major amputation.MedDRA version: 19.0Level: PTClassification code 10062585Term: Peripheral arterial occlusive diseaseSystem Organ Class: 10047065 - Vascular disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- In our study, the effect of autologous cell therapy (ACT) will be compared with repeated percutaneous transluminal angioplasty (re-PTA) in patients with diabetic foot and then will be compared the effect of combination treatment of ACT and re-PTA against re-PTA itself. We suppose an enhanced effect of this combination on on macro- and microcirculation. Expected results of the project include improved tissue oxygenation, enhanced DF healing and a reduced risk of major amputation.
- Sponsor
- Institut klinické a experimentální medicíny
- Enrollment
- 60
- Status
- Active, not recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •To include int the study the following criteria must be fullfilled:
- •1\.diabetic foot disease (DFD; ulcer distal from ankle) or status after minor amputation, in accordance with international classification TEXAS 2C\-3D, Wagner 2\-4 or ischemic rest pain
- •2\.presence of chronic critical limb ischemia attributable to objectively proven arterial occlusive disease (TcPO2\) under 40 mm Hg, indication for re\-PTA
- •3\.age 18\-90 years
- •4\.diabetes mellitus type 1 or 2
- •5\.signed informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range 40
Exclusion Criteria
- •Patients who fullfilled one of these criteria will be excluded:
- •1\.severe active deep infection of DFD
- •2\.deep vein thrombosis less than 6 months
- •3\.severe limb oedema that rule out intramuscular injection of cell suspension
- •4\.severe non\-treated diabetic retinopathy requiring acutely a laser therapy
- •5\.severe haematological disease
- •6\.diagnosed neoplastic process of any organ
- •7\.expected life prognosis shorter than 6 months
- •8\.contracindication of general anestesia
- •9\.females of childbearing potential must be willing to use a highly effective method of contraception (hormonal or barrier method of birth control; abstinence). Contraceptive methods that can achieve a failure rate of less than 1% per year when used consistently and correctly are considered as highly effective birth control methods.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Is it useful to continue administration of gonadotropin releasing hormone (GnRH) agonist after embryo transfer?Infertility treated by ICSIPregnancy and ChildbirthIn vitro fertilizationISRCTN13123887The Egyptian IVF Center (Egypt)446
Active, not recruiting
Not Applicable
Type of gonadotropin and embryo kinetics of developmentEUCTR2014-005331-14-ESIVI Madrid
Completed
Not Applicable
ignocaine infusion to reduce propofol consumption in laparoscopic cholecystectomyJPRN-UMIN000042101Manipal Hospitlals, Old airport road ,Bangalore40
Recruiting
Not Applicable
Will prophylactic antibiotics in out of hospital cardiac arrest survivors receiving targeted temperature management prevent poor outcomesOut of hospital cardiac arrestCirculatory SystemISRCTN12258520niversity Health Network50
Completed
Not Applicable
Evaluation of bodyoil fortified with iron, folic acid, vitamin B12 and vitamin D for infant massageCTRI/2017/11/010710Grand Challenges Canada444